The Warburg Way treatment is based on many years of science. At the core is the science of Metabolic Targeting and Cancer Cell Carcinogenesis, as described below, direct from the original patent applications. The methods described may be used to treat any type of cancerous patent applications.
Methods for treating cancer comprising administering a metabolic targeting chemo-immunotherapy regimen are provided. In one embodiment, the metabolic targeting chemo-immunotherapy regimen may include steps of administering a therapeutically effective dose of one or more immunologic agents (e.g., a therapeutic antibody) to stimulate an immune response in a subject having cancer; reducing the patient's blood glucose level; and administering a therapeutically effective dose of one or more chemotherapeutic agents. The methods described may be used to treat any type of cancer, especially malignant and metastatic late stage cancers.
Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow-derived stem cell with a genetically altered cell. Antibodies against ubiquitin are shown to inhibit tumor cell migration.
Over 28,000 treatments based on the science have been safely administered. Documentation regarding the treatments and performance are collected and integrated into an accessible knowledge-base to inform effectiveness, replicability and optimization. Treatments have been utilized for 28 different types of cancer to date (2/2020). Lung, Digestive, Stomach, Breast, Gynecological and Liver treatments are >75% of total treatments delivered to 2/2020.
